Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9000-0.0700 (-1.76%)
At close: 04:00PM EDT
3.9888 +0.09 (+2.28%)
After hours: 07:14PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8876
Avg. Estimate-0.17-0.16-0.65-0.7
Low estimate-0.25-0.25-1.01-0.99
High estimate-0.13-0.12-0.5-0.45
Year ago EPS-0.14-0.11-0.51-0.65
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8896
Avg. Estimate10.84M11.49M47.55M67.86M
Low estimate8.9M9.22M36.9M46.4M
High estimate18.29M17.36M77.46M117.86M
Year ago sales12.19M10.06M38.02M47.55M
Sales growth (year/est)-11.10%14.30%25.00%42.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.14-0.13-0.13-0.13
Actual EPS-0.14-0.11-0.1-0.17
Difference00.020.03-0.04
Surprise %0.00%15.40%23.10%-30.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.16-0.65-0.7
7 days ago-0.16-0.15-0.64-0.69
30 days ago-0.16-0.15-0.64-0.69
60 days ago-0.16-0.15-0.62-0.66
90 days ago-0.12-0.13-0.61-0.67
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-21.40%N/AN/AN/A
Next qtr.-45.50%N/AN/AN/A
Current year-27.50%N/AN/AN/A
Next year-7.70%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A